1. Wilson SA, Stem LA, Bruehlman RD. Hypothyroidism: Diagnosis and Treatment. Am Fam Physician. 2021;103(10):605-13.
2. Mahmood AM, Allami RH, Issa YW. Impact of single nucleotide polymorphisms of immune checkpoint CTLA-4 (SNP rs231775 and rs5742909) in susceptibility to Hashimoto's thyroiditis patients. J Adv Biotechnol Exp Ther. 2023;6(3):23-33. [
DOI:10.5455/jabet.2024.d02]
3. Martinez Quintero B, Yazbeck C, Sweeney LB. Thyroiditis: Evaluation and Treatment. Am Fam Physician. 2021;104(6):609-17.
4. Wrońska K, Hałasa M, Szczuko M. The Role of the Immune System in the Course of Hashimoto's Thyroiditis: The Current State of Knowledge. Int J Mol Sci. 2024;25(13):6883. [
DOI:10.3390/ijms25136883] [
PMID] [
PMCID]
5. Moini J, Pereira K, Samsam M. Epidemiology of thyroid disorders: Elsevier; 2020. [
DOI:10.1016/B978-0-12-818500-1.00001-3]
6. Ali Shareef S, Allami RH, Al-ezzy RM, editors. Correlation between Interleukin-23, Autoantibodies and Thyroid Profile in a Sample of Iraqi Patients with Hashimoto's Thyroiditis. Bristol, United Kingdom: IOP Publishing. 2024. [
DOI:10.1088/1755-1315/1325/1/012024]
7. Sawsan AO, Elmubarak M. Causes and Management of Hypothyroidism. In:Hypothyroidism - Causes, Screening and Therapeutic Approaches. London, United Kingdom: IntechOpen. 2024. [
DOI:10.5772/intechopen.1005433]
8. Atkinson A, Esenabhalu V. Hashimoto's Disease: Associated Thyroid Gland Disorders, Pharmacological, and Nutritional Interventions. Open J End Metab Dis. 2022;12(10):211-24. [
DOI:10.4236/ojemd.2022.1210016]
9. Mahmood AM, Allami RH, Issa YW. Impact of single nucleotide polymorphisms of immune checkpoint CTLA-4 (SNP rs231775 and rs5742909) in susceptibility to Hashimoto's thyroiditis patients. J Adv Biotechnol Exp Ther. 2023;7(1):23-33. [
DOI:10.5455/jabet.2024.d02]
10. Shareef SA, Al-ezzy RM, Allami RH. Cytogenetic Analysis Associated with Hashimoto's Thyroiditis in Samples of Iraqi Patients: an in vitro study. J Biotechnol Res Cent. 2024;18(2):65-72. [
DOI:10.24126/jobrc.2024.18.2.790]
11. Iwamoto Y, Kimura T, Itoh T, Mori S, Sasaki T, Sugisaki T, et al. Structural and functional differences in auto-antibody positive compared to auto-antibody negative hypothyroid patients with chronic thyroiditis. Sci Rep. 2023;13(1):15542. [
DOI:10.1038/s41598-023-42765-z] [
PMID] [
PMCID]
12. Li J, Huang Q, Sun S, Zhou K, Wang X, Pan K, et al. Thyroid antibodies in Hashimoto's thyroiditis patients are positively associated with inflammation and multiple symptoms. Sci Rep. 2024;14(1):27902. [
DOI:10.1038/s41598-024-78938-7] [
PMID] [
PMCID]
13. Li C, Zhou J, Huang Z, Pan X, Leung W, Chen L, et al. The Clinical Value and Variation of Antithyroid Antibodies during Pregnancy. Dis Markers. 2020;2020:8871951. [
DOI:10.1155/2020/8871951] [
PMID] [
PMCID]
14. Migliorini P, Italiani P, Pratesi F, Puxeddu I, Boraschi D. The IL-1 family cytokines and receptors in autoimmune diseases. Autoimmun Rev. 2020;19(9):102617. [
DOI:10.1016/j.autrev.2020.102617] [
PMID]
15. Ihim SA, Abubakar SD, Zian Z, Sasaki T, Saffarioun M, Maleknia S, et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment. Front Immunol. 2022;13:919973. [
DOI:10.3389/fimmu.2022.919973] [
PMID] [
PMCID]
16. Liu Z, Wang H, Xiao W, Wang C, Liu G, Hong T. Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis. Int J Exp Pathol. 2010;91(5):420-5. [
DOI:10.1111/j.1365-2613.2010.00715.x] [
PMID] [
PMCID]
17. Storjord E, Hennø LT, Mollnes TE, Brekke OL. Analysis of cytokines. Tidsskr Nor Laegeforen. 2020;140(1). [
DOI:10.4045/tidsskr.18.0961] [
PMID]
18. Waxman C, Lind T. Blood sample collection and handling. In Advanced monitoring and procedures for small animal emergency and critical care. dling. In Advanced Monitoring and Procedures for Small Animal Emergency and Critical Care. (eds Burkitt Creedon JM, Davis H). Hoboken, NJ, USA: John Wiley & Sons, Inc. 2023. pp. 699-715. [
DOI:10.1002/9781119581154.ch53]
19. Al Her MH, Al-Juhaishi AMR, Hm AA. Effect of CYP2D6* 10 (100C> T) Polymorphisms on Clomiphene Citrate Response in Iraqi Women with PCOS. Karbala J Pharm Sci. 2025;16(26):125-36. [
DOI:10.62472/kjps.v16.i26.125-136]
20. Bruijns B, Hoekema T, Oomens L, Tiggelaar R, Gardeniers H. Performance of spectrophotometric and fluorometric DNA quantification methods. Analytica. 2022;3(3):371-84. [
DOI:10.3390/analytica3030025]
21. Khehra N, Padda IS, Zubair M. Polymerase Chain Reaction (PCR). 2025. StatPearls Publishing, Treasure Island (FL).
22. Belmont J. 96 - Molecular Methods. In: Fifth, editor. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM, editors Clinical Immunology: London, United Kingdom: Elsevier; 2019. pp. 1297-310.e1.
23. Sadiq NA-HS, Aziz DZ. The interplay between IL-18 rs1946518 polymorphism, TSH dysregulation, and vitamin D3 deficiency in Hashimoto's thyroiditis. Human Gene. 2025;46:201465. [
DOI:10.1016/j.humgen.2025.201465]
24. Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Ishii R, et al. Association of interleukin-18 gene promoter polymorphisms in type 1 diabetes and autoimmune thyroid disease. Ann N Y Acad Sci. 2003;1005:436-9.
https://doi.org/10.1196/annals.1288.074 [
DOI:10.1196/annals.1288.055] [
PMID]
25. Huang CY, Ting WH, Lo FS, Wu YL, Chang TY, Chan HW, et al. The IL18 gene and Hashimoto thyroiditis in children. Hum Immunol. 2013;74(1):120-4. [
DOI:10.1016/j.humimm.2012.10.005] [
PMID]
26. Karakaya D, Çakmak Genc G, Karakas Celik S, Aktas T, Bayraktaroglu T, Dursun A. Association between IL-18 gene polymorphisms and Hashimoto thyroiditis. Mol Biol Rep. 2021;48(10):6703-8. [
DOI:10.1007/s11033-021-06659-5] [
PMID]
27. Pan HF, Leng RX, Ye DQ. Lack of association of interleukin-18 gene promoter− 607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis. Lupus. 2011;20(9):945-51. [
DOI:10.1177/0961203311400114] [
PMID]
28. Inoue N, Watanabe M, Nakaguchi A, Ueda D, Kawaguti H, Hidaka Y, et al. Functional polymorphisms affecting Th1 differentiation are associated with the severity of autoimmune thyroid diseases. Endocr J. 2017;64(7):695-703. [
DOI:10.1507/endocrj.EJ16-0551] [
PMID]